Neocannbio
The startup develops cannabinoid-based pharmaceuticals targeting intractable brain diseases, utilizing NOID compounds and localized formulations for epilepsy treatment. This approach provides healthcare companies with effective therapeutic options for patients suffering from severe neurological conditions.
Traction –/10
Seoul, South Korea · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops cannabinoid-based pharmaceuticals targeting intractable brain diseases, utilizing NOID compounds and localized formulations for epilepsy treatment. This approach provides healthcare companies with effective therapeutic options for patients suffering from severe neurological conditions.